Table of Contents Table of Contents
Previous Page  83 / 220 Next Page
Information
Show Menu
Previous Page 83 / 220 Next Page
Page Background

81

Explanatory statement

The following Explanatory Statement, as required by Section 102 of the Companies Act, 2013, sets out material facts including

the nature and concern or interest of the Directors in relation to the items of Special business under Item number 05, 06, 07,

08, 09, 10, 11, 12 and 13 mentioned in the accompanying Notice:

Item number 05

Deloitte Haskins & Sells LLP, Chartered Accountants were appointed as the Statutory Auditors of the Company at the 40

th

Annual

General Meeting (AGM) held on July 28, 2017 until the conclusion of 45

th

AGM subject to ratification at every AGM in terms of

Section 139 of the Companies Act, 2013. The recent amendments in law have dispensed with the requirement of ratification

of the Statutory Auditors in AGM subsequent to their appointment. Considering the change in law, ratification of the Statutory

Auditors is not required and accordingly the Resolution number 5 passed at the 40

th

AGM of the Company held on July 28, 2017

is proposed to be modified by dropping the words “subject to ratification at every AGM” therein to align it with the amended

provisions of the Companies Act, 2013.

The Board seeks approval of the aforesaid modification by the Members and accordingly requests their approval of the

Ordinary Resolution.

Memorandum of interest

None of the Directors or Key Managerial Personnel of the Company and their relatives are concerned or interested, financially or

otherwise, in the said Resolution.

Item number 06

The Members in the AGM held on July 26, 2013 had appointed Mr S S Lalbhai as the Chairman and Managing Director (CMD)

of the Company for a period of 5 years, effective July 01, 2014. The current term of his office is due to expire on June 30, 2019.

Mr Lalbhai has 34 years of experience with the Company and has made significant contribution in its growth. It is now proposed

to reappoint him as the CMD of the Company for further period of 5 years commencing July 01, 2019. The Board has approved

proposal for his reappointment as the CMD. His brief résumé is as under:

Name

Mr S S Lalbhai

Date of birth

March 15, 1960

Brief résumé

Mr S S Lalbhai is the Chairman of the Board of the Company since August 2007 and Managing

Director since June 1984. He is a Member of the Corporate Social Responsibility Committee,

Investment Committee and the Stakeholders Relationship Committee of the Board.

Mr Lalbhai is a Member of the Governing Council of Shree Vallabh Shikshan Ashram and a Trustee

on the Board of BAIF Development Research Foundation (BAIF). He is the Chairman of the Finance

Committee and HR Committee of BAIF. He is the Chairman of DHRUVA and GRISERV, two trusts

promoted by BAIF. He is a Trustee or a Member of some of the other social institutions established

by the Lalbhai Group.

Mr Lalbhai holds a post graduate degree in Chemistry from the University of Massachusetts and a

post graduate degree in Economic Policy and Planning from Northeastern University.

Directorship in other companies

Public companies

Amal Ltd – Chairman

Atul Bioscience Ltd – Chairman

Atul Rajasthan Date Palms Ltd – Vice Chairman

Navin Fluorine International Ltd

Pfizer Ltd

Membership in committees of other

companies

Chairman of Committee

Navin Fluorine International Ltd – Nomination and Remuneration Committee

Member of Committees

Amal Ltd – Nomination and Remuneration Committee

Navin Fluorine International Ltd – Audit Committee

Pfizer Ltd – Stakeholders Relationship Committee

Relationship with other Directors

None

Number of shares held in the Company 91,772

The terms of reappointment of Mr Lalbhai are in accordance with applicable provisions of the Companies Act, 2013.

The terms and conditions of the reappointment of Mr Lalbhai are set out in the draft Agreement, which is placed before the

meeting.